剖宫产瘢痕龛与盆腔疼痛:系统综述与Meta分析
该系统综述与Meta分析检索MEDLINE、EMBASE、PubMed、Cochrane CENTRAL和CINAHL至2025年2月20日,纳入64项报告剖宫产瘢痕龛(CSN)患者疼痛的研究。CSN患者痛经、性交痛和慢性盆腔痛(CPP)风险均升高,确诊CSN者痛经患病率38.2%、性交痛28.2%、CPP 26.8%、耻骨上疼痛32.5%,药物或手术治疗均显著减轻疼痛症状(OR 0.13,95%CI 0.08-0.23)。
要点
- CSN患者痛经风险RR 2.25(95%CI 0.90-5.63),性交痛RR 2.06(95%CI 1.42-2.99),CPP RR 2.72(95%CI 1.63-4.54)。
- 确诊CSN者痛经患病率38.2%、性交痛28.2%、CPP 26.8%、耻骨上疼痛32.5%。
- 药物或手术治疗CSN后疼痛症状显著减轻(OR 0.13,95%CI 0.08-0.23)。
核心结论
- CSN与多种盆腔疼痛症状存在强关联。
- 未来研究需统一命名和疼痛报告标准。
研究设计与样本
- 系统综述与Meta分析,检索MEDLINE、EMBASE、PubMed、Cochrane CENTRAL和CINAHL自建库至2025年2月20日。
- 纳入随机对照试验、前瞻性和回顾性队列及病例系列,对象为有影像学诊断CSN且有疼痛结局的症状患者。
- 采用Robins-I工具评估偏倚风险,方案在PROSPERO注册(CRD42022346443)。
- 共64项研究报告CSN患者疼痛(痛经、性交痛、CPP、耻骨上疼痛)。
主要发现
- 与无CSN者相比,CSN患者痛经风险RR 2.25(95%CI 0.90-5.63),性交痛风险RR 2.06(95%CI 1.42-2.99),CPP风险RR 2.72(95%CI 1.63-4.54)。
- 确诊CSN者痛经患病率38.2%(95%CI 28.8-48.6),性交痛28.2%(95%CI 15.3-46.0),CPP 26.8%(95%CI 18.6-36.9),耻骨上疼痛32.5%(95%CI 18.6-36.9)。
- 药物或手术治疗CSN均显著减轻疼痛症状(OR 0.13,95%CI 0.08-0.23)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 多数研究因结局指标缺乏标准化而存在高测量偏倚风险。
- 未来研究需统一命名和疼痛报告标准。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Pain is a long-accepted but inadequately explored symptom of cesarean scar niche (CSN) and it is important to systematic assess the prevalence and features of pelvic pain associated with CSN, also referred to as cesarean scar defect or isthmocele. The purpose of this study is to evaluate the association between CSN and pelvic pain. DATA SOURCES: A comprehensive strategy was used to search MEDLINE, EMBASE, Pub Med, Cochrane CENTRAL, and CINAHL from database inception to February 20th, 2025. METHODS OF STUDY SELECTION: We included randomized controlled trials, prospective and retrospective cohorts, and case series involving symptomatic patients with a radiological diagnosis of CSN that evaluated pain as an outcome. Risk of bias was assessed with the Robins-I tool. The protocol was registered in PROSPERO (CRD42022346443). TABULATION, INTEGRATION AND RESULTS: The primary outcome was prevalence of pelvic pain in patients with confirmed CSN. Other outcomes included the risk of pain in patients with CSN compared those without, and changes in pain symptoms following medical or surgical management of niche. Sixty-four studies reported on pain (dysmenorrhea, dyspareunia, chronic pelvic pain (CPP), suprapubic pain (SPP)) in patients with CSN. Patients with a CSN were at increased risk of dysmenorrhea (RR: 2.25, 95% CI, 0.90-5.63), dyspareunia (RR: 2.06 95% CI, 1.42-2.99), and CPP (2.72, 95% CI, 1.63-4.54) compared to those without. In patients with confirmed niche, the prevalence of dysmenorrhea was 38.2% (95% CI 28.8-48.6); dyspareunia 28.2% (95% CI 15.3-46.0); CPP 26.8% (95% CI, 18.6-36.9) and SPP 32.5% (95% CI, 18.6-36.9). Both medical and surgical treatment of CSN significantly reduced pain symptoms (OR: 0.13, 95% CI, 0.08-0.23). Most studies were high risk for measurement bias due to lack of standardization for outcome measures. CONCLUSION: There is a strong association between CSN and various pelvic pain symptoms. Future studies require standardization of nomenclature and reporting for pain in this context.
引用
- Min N, Thiel P, McGrattan M, et al. Cesarean Scar Niche and Pelvic Pain: A Systematic Review and Meta-Analysis. J Minim Invasive Gynecol. 2025. PMID: 40680988. doi:10.1016/j.jmig.2025.07.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。